EPRS
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
EPRS
Delisted
EPRS was delisted on the 3rd of August, 2016.
24 hedge funds and large institutions have $17.2M invested in EPIRUS BIOPHARMACEUTICALS INC COM in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
2
Reduced
4
Closed
5
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$89K
Top Buyers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$425K |
| 2 |
Renaissance Technologies
New York
|
+$204K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$112K |
| 4 |
SIM
Spark Investment Management
New York
|
+$98K |
| 5 |
Goldman Sachs
New York
|
+$60K |
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
-$216K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$154K |
| 3 |
Jennison Associates
New York
|
-$89K |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$75.9K |
| 5 |
A
Abingworth
London,
United Kingdom
|
-$56K |
